Home
Discovering the relationships at the heart of biology to cure disease.
We are an end-to-end biotech developing transformational medicines, with technology at our core.
Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell multi-omics directly from patient tissue, functional assays and machine learning to drive at disease understanding — from cause to cure.
Our science
Medicines born from high-resolution biology, machine learning and clinical insights.
Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select druggable targets and develop transformational medicines.
![Image of Relation employee](https://plain-wapiti.transforms.svdcdn.com/production/home-1.webp?w=1164&h=1044&q=80&auto=format&fit=crop&crop=focalpoint&fp-x=0.5&fp-y=0.5&dm=1708368443&s=9133f3aae7d06d619dc99a0f15060ab5)
Our team
Interdisciplinary collaboration.
Immense impact.
Relation is led by experienced drug developers, computational scientists and entrepreneurs with experience across biotech, pharma, venture and academic research. We have a hunger to transform drug development as we know it — because the patient is waiting.
![Image of Relation employees](https://plain-wapiti.transforms.svdcdn.com/production/home-2.webp?w=1164&h=1044&q=80&auto=format&fit=crop&crop=focalpoint&fp-x=0.5&fp-y=0.5&dm=1708368427&s=72b159db93bf9c6e4fd634ec2372a652)
Timeline
-
Jan 2020
Company founded by Charles Roberts, Benjamin Swerner and Jake Taylor-King
-
Sept 2020
Relation, Yoshua Bengio, Mila and Scripps Research awarded grant from Bill and Melinda Gates Foundation
-
Mar 2022
Relation awarded access to NVIDIA's CAMBRIDGE-1, the UK's most powerful supercomputer, to power digital biology breakthroughs
-
April 2022
David Roblin moves from Non-Executive Director to CEO
-
June 2022
$25M raised led by DCVC and Magnetic
-
Feb 2023
Nobel laureate Sir Paul Nurse opens Relation Labs
-
March 2023
Relation announces osteoporosis as its first indication
-
March 2024
Relation announces $60M seed financing closure
![](/dist/images/relation-cta.png)
Join our team.
We are seeking world-class talent across biology, machine learning and drug discovery. Explore our opportunities here.
Read our news
Read more-
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm
GlobalNewswire
Press release 14 Mar 2024
-
Exclusive: ‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work
Endpoints News
In the news 13 Mar 2024
-
Season combinatorial intervention predictions with Salt & Peper
OpenReview
Scientific publication 03 Mar 2024
-
Can single-cell biology realize the promise of precision medicine?
Nature Biotechnology
Scientific publication 15 Feb 2024